Elevate Your T-Cell Manufacturing Process

Expanding autologous T-cells for clinical and commercial applications can be challenging when done using traditional methods, due to the high risk of lot-to-lot-variability, contamination and long timespan. In this webinar, Lead Research Scientist Mindy Miller Ph. D, and Laboratory Scientist Annie Cunningham from Terumo Blood and Cell Technologies walk through techniques and steps to consider when scaling up T-Cell production and improving your manufacturing.

In this webinar we learn how to streamline the manufacturing process to minimize risks due to open events, take a deep dive into T-cell data on the small and standard bioreactor, review data on minimal seeding requirements for process development, and scale from process development to manufacturing on the same platform.